Liquid biopsy is an innovative and increasingly influential method in cancer diagnostics, offering significant advantages over traditional tissue biopsy by detecting cancer information through a simple blood sample. This non-invasive technique allows for the detection of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other cancer-related biomarkers in the bloodstream. In this post, we explore how liquid biopsy is transforming cancer detection and monitoring, and how Electronic Data Capture (EDC) systems like ClinCapture’s Captivate EDC are crucial in collecting and managing this vital data.
Revolutionizing Cancer Diagnostics with Liquid Biopsy
Liquid biopsy provides a less invasive, more frequent, and dynamic option for monitoring tumor genomes than traditional biopsies, which often require surgical procedures. This method is particularly valuable for tracking treatment responses, detecting resistance mutations, and identifying minimal residual disease. The ability to perform serial biopsies easily over time offers oncologists a real-time “snapshot” of the tumor’s genetic landscape, facilitating personalized treatment adjustments and better patient management.
Read full article here: